A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

Abroad (travel likely)RecruitingPHASE2

Conditions

Tuberculosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

TASK, Cape Town, Western Cape, South Africa
Contact: Study coordinator (Gifty Okyere-Manu, MBChB) · drgifty@task.org.za · +27 21 831 6564
Contact: Study coordinator (Vani Govender, Honors Medical Biochemistry) · vani.g@task.org.za · +27 21 831 6564
Contact: Principal Investigator (Gifty Manu-Okyere, MBChB)
Fairoez Ryklief, MBChB (Sub-investigator)
Trishnabye Mahadea, MBChB (Sub-investigator)

Study leads

Gifty Okyere-Manu, MBChB
Principal Investigator
TASK

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Shortened Regimen for Drug-susceptible TB in Children

Tuberculosis · Tuberculosis, Pulmonary · Tuberculosis, Lymph Node

Abroad (travel likely)RecruitingPHASE3

Chennai, India · Pune, India

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Tuberculosis, Multidrug-Resistant

Abroad (travel likely)RecruitingPHASE2

Maputo, Mozambique · Dasmariñas, Philippines

Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

Drug Susceptible Pulmonary Tuberculosis

Abroad (travel likely)RecruitingPHASE2

Johannesburg, South Africa · Pretoria, South Africa

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Pathogen Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China